Research led by Seng Chan You, MD, at the Yonsei University College of Medicine, Korea, has investigated the risk of cancer associated with use of the drug ranitidine compared to other histamine-2 receptor antagonists (H2RAs) ...
A combination immunotherapy treatment of nivolumab plus ipilimumab was associated with no improvement in survival for advanced cancers other than melanoma, when compared to nivolumab alone, according to a recent Northwestern ...
Sep 22, 2023
0
39
A new meta-analysis combining 22 studies, to be presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2–6 October), shows that tirzepatide is superior to semaglutide ...
Sep 22, 2023
0
8
A team from the UCL Global Business School for Health (GBSH) and the UCL School of Pharmacy are using data collected from an "electric tongue" to create an AI model for predicting the bitterness of drugs.
Sep 22, 2023
0
5
Artemisinin-based combination therapies (ACTs) are the globally-accepted first-line treatments for malaria—a mosquito-borne disease caused by the Plasmodium falciparum parasite that annually kills around 600,000 people, ...
Sep 21, 2023
0
43
Another diabetes drug maker is taking legal action against businesses in several states, alleging that they're "fraudulently claiming" that their compounded products are the same as its medication.
Sep 21, 2023
0
1
Tennessee last year spent $48 million on a single drug, Humira—about $62,000 for each of the 775 patients who were covered by its employee health insurance program and receiving the treatment. So when nine Humira knockoffs, ...
Sep 21, 2023
0
1
Dabrafenib plus trametinib results in significantly more responses and longer progression-free survival than standard chemotherapy for pediatric patients with low-grade glioma with BRAF V600 mutations, according to a study ...
Sep 21, 2023
0
16
For outpatients with mild-to-moderate COVID-19, inhaled fluticasone furoate does not shorten time to symptom resolution, according to a study published in the Sept. 21 issue of the New England Journal of Medicine.
Sep 21, 2023
0
32
A Food and Drug Administration advisory panel concluded last week that the decongestant phenylephrine, contained in many over-the-counter cold remedies—including some formulations of popular brands like Sudafed, Tylenol, ...
Sep 21, 2023
0
0
